Top ▲
This section gives an overview of the disease, and where available shows the following:
More information can be found in the help pages.
✖Disease ID: | 84 | |
Name: | Aspirin exacerbated respiratory diseases | |
Associated with: | 1 target | |
1 immuno-relevant ligand |
Click on the target name to link to its detailed view page
Where available, information is display on the role of the target in the disease; drugs which target the disease and their therapeutic use and side-effects.
If there is mutation data curated in GtoPdb this is indicated, with a link back to the appropriate section on the target detailed view page
Immuno ligand interactions - If available, a table of immuno-relevant ligands is shown. These ligands have been curated as having an association to the disease and possess interaction data with the target in GtoPdb. The approval status of the ligand is shown, along with curator comments and an indication of whether the target is considered the primary target of the ligand.
More information can be found in the help pages.
✖FPR2 | |
References: | 1 |
Click ligand name to view ligand summary page
Click the arrow in the final column to expand comments
More information can be found in the help pages.
✖Key to terms and symbols | Click ligand name to view ligand summary | Click column headers to sort | |||||||||||||||
|
1. Kim HJ, Cho SH, Park JS, Lee TH, Lee EJ, Kim YH, Uh ST, Chung IY, Kim MK, Choi IS et al.. (2012) Association analysis of formyl peptide receptor 2 (FPR2) polymorphisms and aspirin exacerbated respiratory diseases. J Hum Genet, 57 (4): 247-53. [PMID:22377711]
2. Palikhe NS, Kim SH, Cho BY, Ye YM, Choi GS, Park HS. (2010) Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy, 65 (3): 338-46. [PMID:19796209]